Glioblastoma and MiRNAs
Glioblastoma (GB) is one of the most common types of lethal brain tumors. Although several treatment options are available including surgery, along with adjuvant chemo and radiotherapy, the disease has a poor prognosis and patients generally die within 14 months of diagnosis. GB is chemo and radio r...
Main Authors: | Swalih P. Ahmed, Javier S. Castresana, Mehdi H. Shahi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1581 |
Similar Items
-
The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
by: Anna Kirstein, et al.
Published: (2020-04-01) -
Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response
by: Samantha Filipów, et al.
Published: (2019-03-01) -
The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas
by: Sasha Beyer, et al.
Published: (2017-07-01) -
Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients
by: Dóra Géczi, et al.
Published: (2021-05-01) -
Predict Colon Cancer by Pairing Plasma miRNAs: Establishment of a Normalizer-Free, Cross-Platform Model
by: Da Qin, et al.
Published: (2021-04-01)